Navigation Links
Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
Date:7/14/2008

SUNNYVALE, Calif., July 14 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its fiscal second quarter ended June 30, 2008, on Thursday, July 24, 2008 after the close of the market.

The company will host a management presentation at 1:30 p.m. Pacific Time on Thursday, July 24, 2008 to discuss the results. To access the live webcast, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

Interested participants and investors may also listen to the live teleconference call by dialing 866-825-1692 (domestic) or 617-213-8059 (international), and entering participant code 92219619. A replay will be available for seven days beginning at 3:30 p.m. Pacific Time. Access numbers for this replay are 888-286-8010 (domestic) and 617-801-6888 (international), with participant code 37466812.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the a
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Product release is a research industry first, all...ities and research safety study data to be managed... Cedar Knolls, NJ (PRWEB) November 9, 2009 -...as unveiled Pristima™ VM, an integrated ente...hat track the use and care of veterinary research ...
(Date:11/8/2009)...alif. Nov. 5, 2009 Complete Genomics, a third-ge...nounced publication of a report in the journal Sc...latform, including analysis of sequence data from ... for these three genomes sequenced on the proof-of...05 for 87x coverage to $1,726 for 45x coverage for...
(Date:11/6/2009).... 6 BioSpecifics Technol...company developing first-in-class collagenase-base...for the third quarter ended September 30, 2009. ,...f this year, the FDA,s Arthritis Advisory Committe...approval of XIAFLEX(TM) for the treatment of Dupuy...
(Date:11/6/2009)..., November 6 EUCODIS Bioscience, a...nd marketing enzymes for the,chemical industry ann...greement with Bio Sidus, the leading biopharmaceut...ement gives EUCODIS Bioscience exclusive access - ...us, proprietary collection of,psychrophilic bacter...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...e, April 14 /PRNewswire-FirstCall/,-- Cephalon, In...ean,Commission has granted marketing authorization... fentanyl. EFFENTORA is indicated for the treatmen...ents who are already receiving,maintenance opioid ...alon,to market EFFENTORA in the 27 member states o...
...14 ,ExlService Holdings, Inc. (Nasdaq: EXLS ), a ...nnounced that Rembert de Villa has joined as Head ...ervices offerings focus on,helping clients improve...analytics, streamlining and improving business pro...s. Under the banner of Transformation Services,Rem...
...lights New Small Molecule Drug ...EntreMed, Inc.,(Nasdaq: ENMD ), a clinical-stage ... the treatment of cancer and inflammatory diseases...and mechanism of action data for,its selective kin...8, Mark,R. Bray, Ph.D., Vice President, Research, ...
Other Biology Technology:Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain 2Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain 3Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain 4EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 2EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 3EXL Announces Appointment of Rembert de Villa as Head of Transformation Services 4EntreMed's Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session 2EntreMed's Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session 3
(Date:11/6/2009)...ny with their arboreal hosts. But new research sug...es of choice, the ants can get destructive to neig...November issue of the American Naturalist , is th..., and it reopens a centuries-old debate on the rel...rtain species of plants and trees have cozy relati...
(Date:11/5/2009)...rs (NABT) will recognize Leonard C. Yannielli, pro...Community College (NVCC) in Waterbury, Connecticut...he NABT annual professional development conference...o. , The Evolution Education Award is cosponsore...,(AIBS) and Biological Sciences Curriculum Study ...
(Date:11/4/2009)...ctant to officially endorse green tea as a cancer ...t its protective effects, including results of a n..., a journal of the American Association for Cancer...ancer. , Vassiliki Papadimitrakopoulo, M.D., pr...Head and Neck Medical Oncology at the University o...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2FDA OKs Single Dose Plan B Emergency Contraceptive 51533 1Arizona researchers to sequence West African rice strain 51528 1Arizona researchers to sequence West African rice strain 51528 2Arizona researchers to sequence West African rice strain 51528 3Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 1Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 2
...hers at Adelaide,s Women,s & Children,s Hospital a...e a world-first discovery that links viral infecti...re-term birth. , The research findings, published...y, are a major step forward in unravelling the mys...ncy. , The research has been conducted by the Sou...
... Mass. Climate change is rapidly transforming the...cidity of seawater, and altering atmospheric and o... this week at the American Association for the Adv...n. , The vastness of our oceans may have engender...from global climate change, said Jane Lubchenco, t...
...GE, Mass. The evolution of human speech was far m...s to link it to a specific gene, says Robert Berwi... , Berwick will describe his ideas about language...n Association for the Advancement of Science on Su...lmaker, and explores the use of evolutionary resea...
Other Biology News:Herpes virus link to complications in pregnancy 2Climate change has major impact on oceans 2Climate change has major impact on oceans 3Climate change has major impact on oceans 4MIT: No easy answers in evolution of human language 2MIT: No easy answers in evolution of human language 3
Mouse Anti-Human CAPG Monoclonal Antibody, Unconjugated, Clone 6D6 from Abnova Corporation
GeneSnap from SYNGENE
DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.
Mouse Anti-XAGE2 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: